ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 10660 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 10660; 2) Community: the network communities that were significantly associated with the response to NSC 10660; 3) Molecule: the relationships between components within communities and NSC 10660; 4) MDR: the compounds that were significantly associated with the NSC 10660.

NSC Compound Enrichment Correlation
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.036145517892443 0.36401106
NSC 685470 Null 0.036145517892443 0.18727479
NSC 736829 6-(5-Aminopentyl)-5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]i soquinoline Hydrochloride 0.036145517892443 0.30973139
NSC 113951 6-Bromotoyocamycin 0.0376362543535815 0.41248105
NSC 123978 Sarveroside 0.0376362543535815 0.062527226
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0376362543535815 0.24942061
NSC 135371 Null 0.0376362543535815 0.33726082
NSC 138333 Null 0.0376362543535815 0.31243978
NSC 255105 GELDANAMYCIN ANALOG 0.0376362543535815 0.355714
NSC 26273 6-Benzylthioinosine 0.0376362543535815 0.17742083
Total:170  Current:132    [First] [Prev] [Next] [Last]